Henry Schein, Inc. (NASDAQ:HSIC) Shares Sold by PGGM Investments

PGGM Investments lowered its stake in shares of Henry Schein, Inc. (NASDAQ:HSIC) by 0.7% in the fourth quarter, HoldingsChannel reports. The firm owned 107,384 shares of the company’s stock after selling 752 shares during the quarter. PGGM Investments’ holdings in Henry Schein were worth $8,130,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other institutional investors also recently added to or reduced their stakes in the company. Baystate Wealth Management LLC boosted its position in Henry Schein by 2,500.0% during the 3rd quarter. Baystate Wealth Management LLC now owns 520 shares of the company’s stock worth $39,000 after acquiring an additional 500 shares during the period. McGlone Suttner Wealth Management Inc. acquired a new position in Henry Schein during the 4th quarter worth $39,000. Neo Ivy Capital Management bought a new stake in shares of Henry Schein in the 3rd quarter worth $46,000. Covestor Ltd raised its stake in shares of Henry Schein by 22.8% in the 3rd quarter. Covestor Ltd now owns 1,367 shares of the company’s stock worth $102,000 after buying an additional 254 shares in the last quarter. Finally, GAMMA Investing LLC bought a new stake in shares of Henry Schein in the 4th quarter worth $115,000. Institutional investors and hedge funds own 96.62% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of research firms have recently commented on HSIC. Leerink Partnrs reissued a “market perform” rating on shares of Henry Schein in a research note on Monday, February 26th. Evercore ISI boosted their price objective on Henry Schein from $79.00 to $83.00 and gave the stock an “in-line” rating in a research note on Wednesday, February 28th. TheStreet raised Henry Schein from a “c+” rating to a “b-” rating in a research report on Monday, February 26th. Barrington Research boosted their target price on Henry Schein from $82.00 to $90.00 and gave the stock an “outperform” rating in a research report on Wednesday, February 28th. Finally, Piper Sandler boosted their target price on Henry Schein from $78.00 to $86.00 and gave the stock an “overweight” rating in a research report on Monday, February 26th. One analyst has rated the stock with a sell rating, six have assigned a hold rating and five have issued a buy rating to the company. Based on data from MarketBeat, the company presently has an average rating of “Hold” and a consensus target price of $81.09.

Insider Buying and Selling at Henry Schein

In other Henry Schein news, CEO Bradford C. Connett sold 6,430 shares of the business’s stock in a transaction dated Wednesday, March 20th. The stock was sold at an average price of $74.28, for a total value of $477,620.40. Following the transaction, the chief executive officer now owns 73,108 shares in the company, valued at $5,430,462.24. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. In other Henry Schein news, CEO Bradford C. Connett sold 6,430 shares of the business’s stock in a transaction dated Wednesday, March 20th. The stock was sold at an average price of $74.28, for a total value of $477,620.40. Following the transaction, the chief executive officer now owns 73,108 shares in the company, valued at $5,430,462.24. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Vice Chairman James P. Breslawski sold 2,907 shares of the business’s stock in a transaction dated Monday, March 18th. The shares were sold at an average price of $74.37, for a total value of $216,193.59. Following the completion of the transaction, the insider now owns 209,562 shares in the company, valued at approximately $15,585,125.94. The disclosure for this sale can be found here. Corporate insiders own 1.14% of the company’s stock.

Henry Schein Stock Up 0.4 %

NASDAQ:HSIC traded up $0.31 during trading hours on Friday, hitting $73.13. 722,374 shares of the company’s stock traded hands, compared to its average volume of 793,684. The firm has a market cap of $9.40 billion, a P/E ratio of 23.22, a P/E/G ratio of 1.81 and a beta of 0.87. Henry Schein, Inc. has a twelve month low of $60.01 and a twelve month high of $82.63. The company has a debt-to-equity ratio of 0.45, a quick ratio of 1.00 and a current ratio of 1.67. The stock’s fifty day moving average price is $74.17 and its two-hundred day moving average price is $72.42.

Henry Schein (NASDAQ:HSIC) last posted its quarterly earnings results on Tuesday, February 27th. The company reported $0.66 earnings per share for the quarter, missing the consensus estimate of $0.70 by ($0.04). The business had revenue of $3.02 billion for the quarter, compared to analyst estimates of $3 billion. Henry Schein had a net margin of 3.37% and a return on equity of 14.03%. The firm’s quarterly revenue was down 10.5% on a year-over-year basis. During the same period in the previous year, the firm posted $1.21 earnings per share. On average, research analysts expect that Henry Schein, Inc. will post 5.07 earnings per share for the current fiscal year.

Henry Schein Company Profile

Henry Schein, Inc provides health care products and services to dental practitioners and laboratories, physician practices, ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.